Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - ImmunoGen
 More »

  • 10 Minute Charge Heterogeneity Analysis for Development and Quality...
    Karan Shah, Senior Research Associate, Immunogen will review the challenges of analysing antibody drug conjugates (ADC) and present how icIEF allows them to monitor both the charge ...
    11-12-2013
  • Novartis Inks Agreement for ImmunoGen's "TAP" ADC Technology
    launched in 2010. For each license, ImmunoGen receives up-front and milestone payments ... and marketing any products that result from licensing agreements with ImmunoGen. ...
    10-11-2013
  • GEN | Biolinks
    ... Illinois-Missouri Biotechnology Alliance Illumina ImmunoCellular Therapeutics ImmunoGen Imperial College London Incyte InDevR Indiana Economic Development Corporation ...
  • Astellas, Ambrx Launch Up-To-$300M ADC Partnership
    Ambrx is among biotechs that have focused on developing ADCs, hoping to follow in the successful footsteps of drug developers like Roche's Genentech unit and ImmunoGen, which won ...
    4-5-2013
  • Roche's Genentech Wins FDA OK for Breast Cancer Drug
    HER2 protein, Kadcyla was developed by ImmunoGen, and joins three other HER2-positive ... However, ImmunoGen will yet benefit from Kadcyla's approval. While the company was ...
    2-22-2013
  • People in the News
    Before joining Amgen, he was at Dynavax Technologies. Orgenesis appointed Camillo Ricordi, M.D. , to its scientific advisory board...ImmunoGen hired Charles Morris as evp and chief ...
    1-1-2013
  • GEN Reports on Growing Interest in Antibody-Drug Conjugates
    it. Other companies in the GEN article include Ambryx Biotechnology, Spirogen, ADC Therapeutics, Mersana Therapeutics, Seattle Genetics, Roche/Genentech, ImmunoGen, and Pfizer.
    12-10-2012
  • Cancer Research Firms Eye ADCs to Extend Portfolios
    ... ADCs," Chew says, "and collaborates with ImmunoGen, Seattle Genetics, and several others. ... breast cancer with the FDA and EMA. ImmunoGen ImmunoGen has 18 projects in development ...
    12-1-2012
  • 15 Breast Cancer Drugs in the Pipeline Right Now
    ... Trastuzumab emtansine; RG3502) Sponsor: Roche, with linker technology developed by ImmunoGen Method of Action: Antibody-drug conjugate, consisting of the antibody trastuzumab and ...
    11-26-2012
  • Mouse Monoclonal IgM Antibody
    ANPEG-1 is a mouse monoclonal IgM antibody developed using a linear 40 kDa PEG polymer immunogen. It has been used as a positive control antibody in double-bridging immunogenicity ...
    11-15-2012
  • The Importance of Immunogen Selection for Successful Antibodies

    11-1-2012
  • 10 Tips for Selecting The Right Antibody
    They will also dictate what type of immunogen your antibody should have been raised ... Check immunogen details to be doubly sure your antibody will tell you what you want to ...
    8-13-2012
  • Why The AIDS Vaccine Remains Elusive
    Discovering how that happens will be the goal of two new Centers for HIV/AIDS Vaccine Immunology & Immunogen Discovery (CHAVI-ID), one of which will be led by Dr. Haynes at Duke. ...
    8-6-2012
  • Monoclonal Antibodies Enter Golden Age
    Although CHO cells are currently the most popular mAb-producing cells, as second-generation expression systems enter clinical trials and commercialization, Cytovance scientists ...
    8-1-2012
  • Duke, Scripps to Anchor New NIAID-Funded HIV/AIDS Center
    $186 million or more over seven years, to Duke University and The Scripps Research Institute for the new Centers for HIV/AIDS Vaccine Immunology & Immunogen Discovery (CHAVI-ID). ...
    7-13-2012
  • More »

    Journal Articles

  • Three Different Immunogen Preparation Strategies for Production...
    Supansa Pata, Chatchai Tayapiwatana, Watchara Kasinrerk
    Hybridoma
    Three Different Immunogen Preparation Strategies for Production of CD4 Monoclonal ... The intrinsic quality of immunogen is one of the critical success factors. In this study, ...
  • Cross-Clade Immune Responses after Immunization with a Whole...
    RONALD B. MOSS, WIESLAWA GIERMAKOWSKA, PAOLA LANZA, JOHN L. TURNER, MARK R. WALLACE, FRED C. JENSEN, GEORGIA THEOFAN, STEVEN P. RICHIERI, DENNIS J. CARLO
    Viral Immunology
    Cross-Clade Immune Responses after Immunization with a Whole-Killed gp120-Depleted Human Immunodeficiency Virus Type-1 Immunogen in Incomplete Freund's Adjuvant (HIV-1 Immunogen, ...
  • Antioxidant Bioavailability and Rapid Immune-Modulating Effects...
    Gitte S. Jensen, Kimberlee A. Redman, Kathleen F. Benson, Steve G. Carter, Marcie A. Mitzner, Stuart Reeves, Larry Robinson
    Journal of Medicinal Food
    Antioxidant Bioavailability and Rapid Immune-Modulating Effects After Consumption of a Single Acute Dose of a High-Metabolite Yeast Immunogen: Results of a Placebo-Controlled ...
  • HIV-Specific CD4 + and CD8 + Immune Responses Are Generated with...
    Ronald B. Moss, Jocelyn Diveley, Fred C. Jensen, Erin Gouveia, Jay Savary, Dennis J. Carlo
    Journal of Interferon & Cytokine Research
    HIV-Specific CD4 + and CD8 + Immune Responses Are Generated with a gp120-Depleted, Whole-Killed HIV-1 Immunogen with CpG Immunostimulatory Sequences of DNA Journal of Interferon & ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll